ChunhuaLuMDPh.D

Physician

Dr. Lu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1601 Liberty St
Richmond, TX 77469
Phone+1 281-342-6962

Fax+1 281-342-6963

PubMed

Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.
Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen
Nature Communications. 2023-04-26
2 citations
Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
Premal H. Thaker, Liz Y. Han, Aparna A. Kamat, Jesusa M.G. Arevalo, Rie Takahashi
Nature Medicine. 2021-11-19
Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma.
Koji Matsuo, Masato Nishimura, Justin Bottsford-Miller, Jie Huang, Kakajan Komurov
Clinical Cancer Research. 2021-08-01

$InnoCare Announces the Approval of Orelabrutinib in China for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma and Relapsed/Refractory Mantle Cell Lymphoma$
InnoCare Announces the Approval of Orelabrutinib in China for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma and Relapsed/Refractory Mantle Cell LymphomaDecember 27th, 2020